Liu Zhiqiang,Tian Yuan,Men Kuo,Dai Jianrong.Feasibility of treatment planning for 4D-CT high ventilation functional lung avoided radiotherapy in thoracic cancer[J].Chinese Journal of Radiological Medicine and Protection,2024,44(2):105-110
Feasibility of treatment planning for 4D-CT high ventilation functional lung avoided radiotherapy in thoracic cancer
Received:February 17, 2023  
DOI:10.3760/cma.j.cn112271-20230217-00040
KeyWords:4D-CT lung ventilation function  Lung function avoided  Radiotherapy treatment planning  Deep learning
FundProject:国家自然科学基金(11905295,81502649);中国医学科学院医学与健康科技创新工程项目(2022-I2MC&T-B-075);中国癌症基金会"北京希望马拉松"专项基金(LC2021B01)
Author NameAffiliationE-mail
Liu Zhiqiang National Cancer Center/National Clinical Research Center for Cancer/Department of radiation oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China  
Tian Yuan National Cancer Center/National Clinical Research Center for Cancer/Department of radiation oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China tianyuan1981@hotmail.com 
Men Kuo National Cancer Center/National Clinical Research Center for Cancer/Department of radiation oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China  
Dai Jianrong National Cancer Center/National Clinical Research Center for Cancer/Department of radiation oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China  
Hits: 491
Download times: 160
Abstract::
      Objective To establish a radiotherapy treatment planning process of high ventilation functional lung avoided (HVFLA) for thoracic tumors based on 4D-CT lung ventilation functional images and determine the treatment planning strategy of HVFLA radiotherapy, and so as to provide support for the clinical trials of HVFLA radiotherapy in thoracic cancer patients. Methods A deep learning-based 4D-CT lung ventilation functional imaging model was established and integrated into the radiotherapy treatment planning process. Furthermore, ten thoracic cancer patients with 4D-CT simulation positioning were retrospectively enrolled in this study. The established model was used to obtain the 4D-CT lung ventilation functional imaging for each patient. According to the relative value of lung ventilation, the lung ventilation areas are equally segmented into high, medium and low lung ventilation and then imported them into Pinnacle3 treatment planning system. According to the prescription dose of target and dose constraints of organ at risks (OARs), the clinical and HVFLA treatment plans were designed for each patient using volumetric modulated radiotherapy technique, and each plan should meet the clinical requirements and adding dose constraints of high ventilation functional lung for HVFLA plan. The dosimetric indexes of the target, OARs (lungs, heart and cord) and high functional lung (HFL) were used to evaluated the plan quality. The dosimetric indexes included D2, D98 and mean dose of target, V5, V10, V20, V30 and mean dose of lungs and HFL, V30, V40 and mean dose of heart, and D1 cm3 of cord. Paired samples t-test was used for statistical analysis of the two groups of plans. Results The target and OARs of the clinical plan and HVFLA plan meet the clinical requirements. The HVFLA plan resulted in a statistically significant reduction in the mean dose, V5, V10, V20, and V30 of the high functional lung by 1.2 Gy, 5.9%, 4.2%, 2.6%, and 2.3%, respectively (t=-8.07, 4.02, -6.02, -7.06, -6.77,P<0.05). There was no statistical difference in the dosimetric indexes of lungs, heart and cord. Conclusions We established the treatment planning process of HVFLA radiotherapy based on 4D-CT lung ventilation functional images. The HVFLA plan can effectively reduce the dose of HFL, while the doses of lungs, heart and cord had no significant difference compared with the clinical plan. The strategy of HVFLA radiotherapy planning is feasible to provide support for the implementation of HVFLA radiotherapy in thoracic cancer patients.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9061010  On-line:0

v
Scan QR Code
&et=08BA79BB04C4219F73EBFE160F8E62DB0691BD3C2CAF1C71C4BDE1E362C6F25B7B6506945AFFB89846D9E19FEAC86582334368A1224439889754A42935230F80EA274C5BDA83C713E3C78B32C7DBAFB66D5553A417C402D19A7257876C1B931F875924C6188C9B025E782ACAA059C9FDD76820ED8DAE118A&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=B80136CCD8DCBAA1&aid=&vid=&iid=0B39A22176CE99FB&sid=03F1579EF92A5A32&eid=4DB1E72614E68564&fileno=20240204&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="B80136CCD8DCBAA1"; var my_aid="";